OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Shijun Zhang

3 Projects | 1 Researchers | $890,000 Invested

2023

Virginia Commonwealth University

Shijun Zhang, PhD

Probing neuroinflammation in Alzheimer's with NLRP3 PET radiotracers

  • Funding Amount: $600,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Neuroinflammation
  • Status: Active

2016

Virginia Commonwealth University

Shijun Zhang, PhD

Target identification and mode of action studies for novel NLRP3 inflammasome inhibitors

  • Funding Amount: $130,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuroinflammation
  • Status: Closed

2015

Virginia Commonwealth University

Shijun Zhang, PhD

Development of novel NLRP3 inflammasome inhibitors towards Alzheimer's disease

  • Funding Amount: $160,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuroinflammation
  • Status: Closed